Controlling cardiac arrhythmias by lengthening repolarization: rationale from experimental findings and clinical considerations.
Singh
B N
BN
Division of Cardiology, Veterans Administration Affairs Medical Center, West Los Angeles, California 90073.
Sarma
J S
JS
Zhang
Z H
ZH
Takanaka
C
C
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D015220:Calcium Channels / Q000187:drug effects; D006801:Humans; D015221:Potassium Channels / Q000187:drug effects; D013329:Structure-Activity Relationship
D000889:Anti-Arrhythmia Agents; D015220:Calcium Channels; D015221:Potassium Channels